| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.83e-11 | 46 | 25 | 6 | GO:0005245 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 1.73e-09 | 3 | 25 | 3 | GO:0008332 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.90e-09 | 14 | 25 | 4 | GO:0008331 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.04e-08 | 129 | 25 | 6 | GO:0005262 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.66e-08 | 151 | 25 | 6 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.77e-08 | 152 | 25 | 6 | GO:0022843 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 8.10e-08 | 182 | 25 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 8.64e-08 | 184 | 25 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 1.19e-06 | 465 | 25 | 7 | GO:0046873 | |
| GeneOntologyMolecularFunction | gated channel activity | 2.84e-06 | 334 | 25 | 6 | GO:0022836 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 3.31e-06 | 343 | 25 | 6 | GO:0005261 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 4.42e-06 | 26 | 25 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | 8.54e-06 | 627 | 25 | 7 | GO:0022890 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | 1.24e-05 | 664 | 25 | 7 | GO:0008324 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.74e-05 | 459 | 25 | 6 | GO:0005216 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | 2.92e-05 | 758 | 25 | 7 | GO:0015318 | |
| GeneOntologyMolecularFunction | sodium channel activity | 3.68e-05 | 52 | 25 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | channel activity | 3.71e-05 | 525 | 25 | 6 | GO:0015267 | |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | 3.75e-05 | 526 | 25 | 6 | GO:0022803 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | 3.90e-05 | 793 | 25 | 7 | GO:0015075 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 4.63e-04 | 1180 | 25 | 7 | GO:0022857 | |
| GeneOntologyMolecularFunction | transporter activity | 7.88e-04 | 1289 | 25 | 7 | GO:0005215 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.24e-03 | 171 | 25 | 3 | GO:0015081 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 6.00e-03 | 93 | 25 | 2 | GO:0097110 | |
| GeneOntologyMolecularFunction | ATPase binding | 8.02e-03 | 108 | 25 | 2 | GO:0051117 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane transport | 2.22e-07 | 392 | 24 | 7 | GO:0070588 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 2.65e-07 | 48 | 24 | 4 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 2.65e-07 | 48 | 24 | 4 | GO:1902656 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 5.51e-07 | 142 | 24 | 5 | GO:0098659 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 5.51e-07 | 142 | 24 | 5 | GO:0099587 | |
| GeneOntologyBiologicalProcess | calcium ion transport | 1.29e-06 | 509 | 24 | 7 | GO:0006816 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion-dependent exocytosis | 1.56e-06 | 20 | 24 | 3 | GO:0045956 | |
| GeneOntologyBiologicalProcess | calcium ion transmembrane import into cytosol | 4.44e-06 | 217 | 24 | 5 | GO:0097553 | |
| GeneOntologyBiologicalProcess | calcium ion import | 4.73e-06 | 98 | 24 | 4 | GO:0070509 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 5.90e-06 | 230 | 24 | 5 | GO:0098739 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1B HRC CACNA1I CACNA1H CACNA1G CACHD1 CATSPER1 SLC39A10 | 6.00e-06 | 922 | 24 | 8 | GO:0098662 |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1B HRC CACNA1I CACNA1H CACNA1G CACHD1 CATSPER1 SLC39A10 | 7.03e-06 | 942 | 24 | 8 | GO:0098655 |
| GeneOntologyBiologicalProcess | exocytosis | 8.18e-06 | 434 | 24 | 6 | GO:0006887 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 9.64e-06 | 36 | 24 | 3 | GO:0086010 | |
| GeneOntologyBiologicalProcess | metal ion transport | CACNA1B HRC CACNA1I CACNA1H CACNA1G CACHD1 CATSPER1 SLC39A10 | 1.09e-05 | 1000 | 24 | 8 | GO:0030001 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | CACNA1B HRC CACNA1I CACNA1H CACNA1G CACHD1 CATSPER1 SLC39A10 | 1.23e-05 | 1017 | 24 | 8 | GO:0098660 |
| GeneOntologyBiologicalProcess | regulated exocytosis | 1.84e-05 | 291 | 24 | 5 | GO:0045055 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion-dependent exocytosis | 1.90e-05 | 45 | 24 | 3 | GO:0017158 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | CACNA1B HRC CACNA1I CACNA1H CACNA1G CACHD1 CATSPER1 SLC39A10 | 2.40e-05 | 1115 | 24 | 8 | GO:0034220 |
| GeneOntologyBiologicalProcess | regulation of calcium-dependent activation of synaptic vesicle fusion | 2.72e-05 | 7 | 24 | 2 | GO:0150037 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1B HRC CACNA1I CACNA1H CACNA1G CACHD1 CATSPER1 SLC39A10 | 3.14e-05 | 1157 | 24 | 8 | GO:0006812 |
| GeneOntologyBiologicalProcess | neuronal action potential | 5.25e-05 | 63 | 24 | 3 | GO:0019228 | |
| GeneOntologyBiologicalProcess | positive regulation of regulated secretory pathway | 6.04e-05 | 66 | 24 | 3 | GO:1903307 | |
| GeneOntologyBiologicalProcess | regulation of vesicle-mediated transport | 9.14e-05 | 667 | 24 | 6 | GO:0060627 | |
| GeneOntologyBiologicalProcess | membrane fusion | 9.63e-05 | 211 | 24 | 4 | GO:0061025 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle fusion to presynaptic active zone membrane | 1.00e-04 | 13 | 24 | 2 | GO:0031632 | |
| GeneOntologyBiologicalProcess | calcium-dependent activation of synaptic vesicle fusion | 1.00e-04 | 13 | 24 | 2 | GO:0099502 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic vesicle membrane organization | 1.00e-04 | 13 | 24 | 2 | GO:1901634 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | CACNA1B HRC CACNA1I CACNA1H CACNA1G CACHD1 CATSPER1 SLC39A10 | 1.07e-04 | 1374 | 24 | 8 | GO:0006811 |
| GeneOntologyBiologicalProcess | calcium-ion regulated exocytosis | 1.15e-04 | 82 | 24 | 3 | GO:0017156 | |
| GeneOntologyBiologicalProcess | import into cell | 1.61e-04 | 1074 | 24 | 7 | GO:0098657 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 1.82e-04 | 249 | 24 | 4 | GO:0008016 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle fusion to presynaptic active zone membrane | 2.43e-04 | 20 | 24 | 2 | GO:0031630 | |
| GeneOntologyBiologicalProcess | positive regulation of vesicle fusion | 2.43e-04 | 20 | 24 | 2 | GO:0031340 | |
| GeneOntologyBiologicalProcess | regulation of synaptic vesicle membrane organization | 2.43e-04 | 20 | 24 | 2 | GO:1901632 | |
| GeneOntologyBiologicalProcess | positive regulation of exocytosis | 2.54e-04 | 107 | 24 | 3 | GO:0045921 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 2.90e-04 | 112 | 24 | 3 | GO:0019226 | |
| GeneOntologyBiologicalProcess | heart contraction | 3.61e-04 | 298 | 24 | 4 | GO:0060047 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 3.64e-04 | 121 | 24 | 3 | GO:0051899 | |
| GeneOntologyBiologicalProcess | heart process | 4.14e-04 | 309 | 24 | 4 | GO:0003015 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion transport | 4.90e-04 | 323 | 24 | 4 | GO:0051924 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 5.07e-04 | 326 | 24 | 4 | GO:1903522 | |
| GeneOntologyBiologicalProcess | vesicle fusion | 5.82e-04 | 142 | 24 | 3 | GO:0006906 | |
| GeneOntologyBiologicalProcess | synaptic vesicle fusion to presynaptic active zone membrane | 5.91e-04 | 31 | 24 | 2 | GO:0031629 | |
| GeneOntologyBiologicalProcess | organelle membrane fusion | 6.06e-04 | 144 | 24 | 3 | GO:0090174 | |
| GeneOntologyBiologicalProcess | vesicle fusion to plasma membrane | 6.30e-04 | 32 | 24 | 2 | GO:0099500 | |
| GeneOntologyBiologicalProcess | regulation of vesicle fusion | 7.54e-04 | 35 | 24 | 2 | GO:0031338 | |
| GeneOntologyBiologicalProcess | synaptic vesicle membrane organization | 7.98e-04 | 36 | 24 | 2 | GO:0048499 | |
| GeneOntologyBiologicalProcess | regulation of regulated secretory pathway | 8.99e-04 | 165 | 24 | 3 | GO:1903305 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 9.31e-04 | 167 | 24 | 3 | GO:0060048 | |
| GeneOntologyBiologicalProcess | calcium ion transport into cytosol | 1.09e-03 | 42 | 24 | 2 | GO:0060402 | |
| GeneOntologyBiologicalProcess | secretion by cell | 1.12e-03 | 1064 | 24 | 6 | GO:0032940 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion by cell | 1.13e-03 | 404 | 24 | 4 | GO:1903532 | |
| GeneOntologyBiologicalProcess | proteasome-mediated ubiquitin-dependent protein catabolic process | 1.35e-03 | 424 | 24 | 4 | GO:0043161 | |
| GeneOntologyBiologicalProcess | organelle fusion | 1.35e-03 | 190 | 24 | 3 | GO:0048284 | |
| GeneOntologyBiologicalProcess | positive regulation of secretion | 1.48e-03 | 435 | 24 | 4 | GO:0051047 | |
| GeneOntologyBiologicalProcess | action potential | 1.59e-03 | 201 | 24 | 3 | GO:0001508 | |
| GeneOntologyBiologicalProcess | export from cell | 1.70e-03 | 1153 | 24 | 6 | GO:0140352 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 1.75e-03 | 208 | 24 | 3 | GO:0035725 | |
| GeneOntologyBiologicalProcess | striated muscle contraction | 1.97e-03 | 217 | 24 | 3 | GO:0006941 | |
| GeneOntologyBiologicalProcess | cell communication involved in cardiac conduction | 2.13e-03 | 59 | 24 | 2 | GO:0086065 | |
| GeneOntologyBiologicalProcess | secretion | 2.27e-03 | 1221 | 24 | 6 | GO:0046903 | |
| GeneOntologyBiologicalProcess | regulation of metal ion transport | 2.34e-03 | 493 | 24 | 4 | GO:0010959 | |
| GeneOntologyBiologicalProcess | neural precursor cell proliferation | 2.42e-03 | 233 | 24 | 3 | GO:0061351 | |
| GeneOntologyBiologicalProcess | regulation of exocytosis | 2.42e-03 | 233 | 24 | 3 | GO:0017157 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 3.86e-03 | 275 | 24 | 3 | GO:0006814 | |
| GeneOntologyBiologicalProcess | proteasomal protein catabolic process | 3.88e-03 | 567 | 24 | 4 | GO:0010498 | |
| GeneOntologyBiologicalProcess | regulation of monoatomic ion transport | 4.13e-03 | 577 | 24 | 4 | GO:0043269 | |
| GeneOntologyBiologicalProcess | regulation of cytosolic calcium ion concentration | 4.27e-03 | 84 | 24 | 2 | GO:0051480 | |
| GeneOntologyBiologicalProcess | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 4.37e-03 | 85 | 24 | 2 | GO:0032436 | |
| GeneOntologyBiologicalProcess | regulation of cardiac muscle contraction | 4.78e-03 | 89 | 24 | 2 | GO:0055117 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell contraction | 5.20e-03 | 93 | 24 | 2 | GO:0086003 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.39e-11 | 46 | 25 | 6 | GO:0005891 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.47e-10 | 73 | 25 | 6 | GO:0034704 | |
| GeneOntologyCellularComponent | cation channel complex | 2.80e-07 | 235 | 25 | 6 | GO:0034703 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.02e-06 | 17 | 25 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 4.45e-06 | 378 | 25 | 6 | GO:0034702 | |
| GeneOntologyCellularComponent | sodium channel complex | 5.41e-06 | 29 | 25 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | transmembrane transporter complex | 2.82e-05 | 523 | 25 | 6 | GO:1902495 | |
| GeneOntologyCellularComponent | transporter complex | 3.73e-05 | 550 | 25 | 6 | GO:1990351 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 2.64e-04 | 785 | 25 | 6 | GO:0098797 | |
| GeneOntologyCellularComponent | presynaptic active zone | 6.20e-04 | 141 | 25 | 3 | GO:0048786 | |
| MousePheno | abnormal channel response | 1.55e-05 | 33 | 21 | 3 | MP:0003484 | |
| MousePheno | abnormal single cell response | 1.85e-05 | 35 | 21 | 3 | MP:0003463 | |
| MousePheno | fragmentation of sleep/wake states | 7.69e-05 | 9 | 21 | 2 | MP:0009436 | |
| MousePheno | incomplete rostral neuropore closure | 1.63e-04 | 72 | 21 | 3 | MP:0000928 | |
| MousePheno | abnormal rostral neuropore morphology | 1.63e-04 | 72 | 21 | 3 | MP:0012543 | |
| MousePheno | abnormal sleep duration | 1.66e-04 | 13 | 21 | 2 | MP:0021198 | |
| MousePheno | abnormal neuropore morphology | 1.99e-04 | 77 | 21 | 3 | MP:0012542 | |
| MousePheno | abnormal afterhyperpolarization | 2.88e-04 | 17 | 21 | 2 | MP:0003412 | |
| Domain | VDCCAlpha1 | 3.65e-10 | 10 | 23 | 4 | IPR002077 | |
| Domain | VDCC_T_a1 | 1.63e-09 | 3 | 23 | 3 | IPR005445 | |
| Domain | Channel_four-helix_dom | 7.14e-09 | 57 | 23 | 5 | IPR027359 | |
| Domain | - | 7.14e-09 | 57 | 23 | 5 | 1.20.120.350 | |
| Domain | Ion_trans_dom | 2.39e-07 | 114 | 23 | 5 | IPR005821 | |
| Domain | Ion_trans | 2.39e-07 | 114 | 23 | 5 | PF00520 | |
| Domain | Atrophin-like | 1.45e-06 | 2 | 23 | 2 | IPR002951 | |
| Domain | Atrophin-1 | 1.45e-06 | 2 | 23 | 2 | PF03154 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 1.26e-08 | 23 | 17 | 4 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.80e-08 | 25 | 17 | 4 | M47948 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 1.57e-07 | 42 | 17 | 4 | M7169 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 8.25e-07 | 63 | 17 | 4 | M11187 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 1.74e-05 | 43 | 17 | 3 | M1429 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 5.14e-05 | 178 | 17 | 4 | M2890 | |
| Pathway | WP_MAPK_SIGNALING | 1.80e-04 | 246 | 17 | 4 | M39597 | |
| Pathway | KEGG_MAPK_SIGNALING_PATHWAY | 2.47e-04 | 267 | 17 | 4 | M10792 | |
| Pathway | PID_WNT_CANONICAL_PATHWAY | 2.57e-04 | 20 | 17 | 2 | M90 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 1.43e-03 | 47 | 17 | 2 | M19708 | |
| Pathway | REACTOME_MUSCLE_CONTRACTION | 1.72e-03 | 203 | 17 | 3 | M5485 | |
| Pubmed | 1.45e-11 | 8 | 25 | 4 | 28330839 | ||
| Pubmed | 2.61e-11 | 9 | 25 | 4 | 16382099 | ||
| Pubmed | 3.28e-10 | 3 | 25 | 3 | 28846697 | ||
| Pubmed | 3.28e-10 | 3 | 25 | 3 | 33547341 | ||
| Pubmed | Calmodulin regulates Cav3 T-type channels at their gating brake. | 3.28e-10 | 3 | 25 | 3 | 28972185 | |
| Pubmed | Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C. | 3.28e-10 | 3 | 25 | 3 | 23488970 | |
| Pubmed | 3.28e-10 | 3 | 25 | 3 | 11927664 | ||
| Pubmed | 3.28e-10 | 3 | 25 | 3 | 26488564 | ||
| Pubmed | Differential interactions of Na+ channel toxins with T-type Ca2+ channels. | 3.28e-10 | 3 | 25 | 3 | 18591418 | |
| Pubmed | Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart. | 3.28e-10 | 3 | 25 | 3 | 11230107 | |
| Pubmed | 3.28e-10 | 3 | 25 | 3 | 11897840 | ||
| Pubmed | Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy. | 1.31e-09 | 4 | 25 | 3 | 28165634 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | FAM76B ERC2 VGLL3 RERE SLC39A10 ATN1 NKD2 BMP2K PRICKLE3 AXIN1 | 4.81e-09 | 1203 | 25 | 10 | 29180619 |
| Pubmed | 8.37e-09 | 33 | 25 | 4 | 19336002 | ||
| Pubmed | 1.83e-08 | 8 | 25 | 3 | 34478646 | ||
| Pubmed | Intracellular calcium plays an essential role in cardiac development. | 1.83e-08 | 8 | 25 | 3 | 12761855 | |
| Pubmed | 3.92e-08 | 10 | 25 | 3 | 24778262 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 20685979 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 27134080 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 36786913 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 29082441 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 23436820 | ||
| Pubmed | A T-type calcium channel required for normal function of a mammalian mechanoreceptor. | 4.96e-07 | 2 | 25 | 2 | 12808460 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 14988077 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 21079360 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 22574369 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 26627919 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 21622683 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 31042060 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 25071191 | ||
| Pubmed | Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation. | 4.96e-07 | 2 | 25 | 2 | 21438841 | |
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 10814707 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 22886848 | ||
| Pubmed | 4.96e-07 | 2 | 25 | 2 | 22469755 | ||
| Pubmed | β-Adrenergic stimulation increases Cav3.1 activity in cardiac myocytes through protein kinase A. | 4.96e-07 | 2 | 25 | 2 | 22808078 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 24327205 | ||
| Pubmed | Caveolin-3 regulates protein kinase A modulation of the Ca(V)3.2 (alpha1H) T-type Ca2+ channels. | 1.49e-06 | 3 | 25 | 2 | 21084288 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 37739992 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 33299036 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 24966091 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 27353765 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 19131340 | ||
| Pubmed | Association of Catsper1 or -2 with Ca(v)3.3 leads to suppression of T-type calcium channel activity. | 1.49e-06 | 3 | 25 | 2 | 16740636 | |
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 31919478 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 25825486 | ||
| Pubmed | 1.49e-06 | 3 | 25 | 2 | 22572848 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 2.72e-06 | 38 | 25 | 3 | 30786075 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 31800012 | ||
| Pubmed | Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature. | 2.97e-06 | 4 | 25 | 2 | 21788606 | |
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 28655554 | ||
| Pubmed | 2.97e-06 | 4 | 25 | 2 | 17150957 | ||
| Pubmed | T-type calcium channels functionally interact with spectrin (α/β) and ankyrin B. | 4.95e-06 | 5 | 25 | 2 | 29720258 | |
| Pubmed | 4.95e-06 | 5 | 25 | 2 | 12060068 | ||
| Pubmed | 9.38e-06 | 407 | 25 | 5 | 12693553 | ||
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 12900400 | ||
| Pubmed | Histone deacetylase-associating Atrophin proteins are nuclear receptor corepressors. | 1.04e-05 | 7 | 25 | 2 | 16481466 | |
| Pubmed | Rebuilding essential active zone functions within a synapse. | 1.04e-05 | 7 | 25 | 2 | 35176221 | |
| Pubmed | 1.04e-05 | 7 | 25 | 2 | 21057379 | ||
| Pubmed | Functional interactions between Fat family cadherins in tissue morphogenesis and planar polarity. | 1.04e-05 | 7 | 25 | 2 | 22510986 | |
| Pubmed | 4.49e-05 | 14 | 25 | 2 | 21228161 | ||
| Pubmed | 6.70e-05 | 17 | 25 | 2 | 19135992 | ||
| Pubmed | Calcium handling precedes cardiac differentiation to initiate the first heartbeat. | 6.70e-05 | 17 | 25 | 2 | 27725084 | |
| Pubmed | 7.54e-05 | 18 | 25 | 2 | 14645126 | ||
| Pubmed | Msx1 and Msx2 act as essential activators of Atoh1 expression in the murine spinal cord. | 1.14e-04 | 22 | 25 | 2 | 24715462 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.35e-04 | 139 | 25 | 3 | 16985003 | |
| Pubmed | 2.43e-04 | 32 | 25 | 2 | 19320717 | ||
| Pubmed | Ion channel expression in the developing enteric nervous system. | 3.25e-04 | 37 | 25 | 2 | 25798587 | |
| Pubmed | An AUTS2-Polycomb complex activates gene expression in the CNS. | 3.43e-04 | 38 | 25 | 2 | 25519132 | |
| Pubmed | 5.04e-04 | 46 | 25 | 2 | 34815492 | ||
| Pubmed | 5.53e-04 | 225 | 25 | 3 | 12168954 | ||
| Interaction | KRTAP6-2 interactions | 9.01e-08 | 187 | 25 | 6 | int:KRTAP6-2 | |
| Interaction | KRTAP4-12 interactions | 1.43e-06 | 161 | 25 | 5 | int:KRTAP4-12 | |
| Interaction | RNF4 interactions | FAM76B ERC2 VGLL3 RERE SLC39A10 ATN1 NKD2 BMP2K PRICKLE3 AXIN1 | 3.41e-06 | 1412 | 25 | 10 | int:RNF4 |
| Interaction | KDM5B interactions | 6.66e-06 | 100 | 25 | 4 | int:KDM5B | |
| Interaction | KRTAP19-2 interactions | 2.64e-05 | 47 | 25 | 3 | int:KRTAP19-2 | |
| Interaction | KRTAP5-11 interactions | 7.33e-05 | 66 | 25 | 3 | int:KRTAP5-11 | |
| Interaction | TSC1 interactions | 7.57e-05 | 366 | 25 | 5 | int:TSC1 | |
| Interaction | THAP2 interactions | 1.14e-04 | 13 | 25 | 2 | int:THAP2 | |
| Interaction | KRTAP1-1 interactions | 1.43e-04 | 219 | 25 | 4 | int:KRTAP1-1 | |
| Interaction | MDFI interactions | 1.61e-04 | 430 | 25 | 5 | int:MDFI | |
| Interaction | KRTAP4-7 interactions | 1.75e-04 | 16 | 25 | 2 | int:KRTAP4-7 | |
| Interaction | KRTAP4-11 interactions | 1.97e-04 | 92 | 25 | 3 | int:KRTAP4-11 | |
| Interaction | KRTAP19-5 interactions | 2.44e-04 | 99 | 25 | 3 | int:KRTAP19-5 | |
| Interaction | KRTAP9-8 interactions | 2.52e-04 | 100 | 25 | 3 | int:KRTAP9-8 | |
| Interaction | KRTAP6-1 interactions | 2.75e-04 | 103 | 25 | 3 | int:KRTAP6-1 | |
| Interaction | SIAH2 interactions | 2.83e-04 | 104 | 25 | 3 | int:SIAH2 | |
| Interaction | CACNB1 interactions | 4.36e-04 | 25 | 25 | 2 | int:CACNB1 | |
| Interaction | KRTAP12-2 interactions | 5.20e-04 | 128 | 25 | 3 | int:KRTAP12-2 | |
| Interaction | KRTAP4-2 interactions | 5.68e-04 | 132 | 25 | 3 | int:KRTAP4-2 | |
| Interaction | EFEMP2 interactions | 6.20e-04 | 136 | 25 | 3 | int:EFEMP2 | |
| Interaction | OLIG3 interactions | 6.29e-04 | 30 | 25 | 2 | int:OLIG3 | |
| Interaction | KRTAP9-3 interactions | 6.75e-04 | 140 | 25 | 3 | int:KRTAP9-3 | |
| Interaction | TRIM42 interactions | 8.08e-04 | 149 | 25 | 3 | int:TRIM42 | |
| Interaction | KRTAP9-2 interactions | 8.08e-04 | 149 | 25 | 3 | int:KRTAP9-2 | |
| Interaction | DVL1 interactions | 8.40e-04 | 151 | 25 | 3 | int:DVL1 | |
| Interaction | TRIP6 interactions | 9.22e-04 | 358 | 25 | 4 | int:TRIP6 | |
| Interaction | CDPF1 interactions | 9.58e-04 | 37 | 25 | 2 | int:CDPF1 | |
| Interaction | NR2E1 interactions | 1.01e-03 | 38 | 25 | 2 | int:NR2E1 | |
| Interaction | AUTS2 interactions | 1.12e-03 | 40 | 25 | 2 | int:AUTS2 | |
| Interaction | RIMS1 interactions | 1.12e-03 | 40 | 25 | 2 | int:RIMS1 | |
| Interaction | PLSCR1 interactions | 1.22e-03 | 172 | 25 | 3 | int:PLSCR1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p12 | 7.31e-04 | 73 | 25 | 2 | chr3p12 | |
| GeneFamily | Calcium voltage-gated channel subunits | 7.89e-09 | 26 | 17 | 4 | 253 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | 1.12e-06 | 891 | 25 | 8 | M45033 | |
| ToppCell | LPS_only-Endothelial-Epi-like|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.72e-05 | 126 | 25 | 3 | 4c598f7bae09aca7a4ecce63dfd6890b26468c73 | |
| ToppCell | LPS_only-Endothelial-Epi-like-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.72e-05 | 126 | 25 | 3 | e065304f480a5e38532b66508b0ee87cc48bba9b | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 6.87e-05 | 143 | 25 | 3 | 10955b54e4a87d035093a2756291ef1d6a14ab63 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 162 | 25 | 3 | 966df4558140c3d541999ab553f201ae76a1c401 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.94e-05 | 162 | 25 | 3 | 22f1abd20f43bc7e7fc46969da9962faf70ae5d2 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-04 | 167 | 25 | 3 | e1b1a952fce27ab9cf16919b290625ff4a75261e | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 175 | 25 | 3 | 59249c9e83952d7277010e7be3c779e26399eb5d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 175 | 25 | 3 | b35cc1357495f2a03a6500f807c6e6f8c877734d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-04 | 177 | 25 | 3 | b872ee91e01265b101b81bd304cf6b95d5419e68 | |
| ToppCell | VE-matDC-|VE / Condition, Cell_class and T cell subcluster | 1.38e-04 | 181 | 25 | 3 | 6252184ef098b911df50be4fe1b5565849a5b6b8 | |
| ToppCell | VE-matDC|VE / Condition, Cell_class and T cell subcluster | 1.38e-04 | 181 | 25 | 3 | 982fd96ef75bc9ab2c2f4970c01b76ba7a164871 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.52e-04 | 187 | 25 | 3 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.62e-04 | 191 | 25 | 3 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.62e-04 | 191 | 25 | 3 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.62e-04 | 191 | 25 | 3 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.64e-04 | 192 | 25 | 3 | 4c35e5c28a40b439044797ba1f06cb7c36b2a8de | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.82e-04 | 199 | 25 | 3 | 1295f34a350bf48987e2fad411aaac3630efd3f1 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | 16f468217427921fa18c6d078ffa990eb019b257 | |
| ToppCell | Macroglial-Astrocytes|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | 941536b7c32f1e63c70535233b2ccce0cd7bf96e | |
| ToppCell | Macroglial-Astrocytes-SLC14A1-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | 01819446deeab9054f5cfe889d53bb49d137dbc0 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | d6fcbf4f4bc1b89a9929d7b114c6b907b6979900 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1----L1-6|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | f861509b54185d89931db64da1b9d81986cc7938 | |
| ToppCell | Macroglial-Astrocytes-SLC14A1--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 1.85e-04 | 200 | 25 | 3 | 0442894c39eec69850c090957a5dc7bcecd21e04 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1-Excitatory_Neuron.Slc17a7.Fibcd1-Nrip3_(CA1_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.97e-04 | 59 | 25 | 2 | 172f1c6fdc8005a6f21d68a4dc0f8631c265d9e5 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Excitatory_Neuron.Slc17a6.Nell1_(Neuron.Slc17a6.Nell1)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.80e-04 | 69 | 25 | 2 | 11e6747ed4a45acee210c48ba670bfe0375fb19b | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Excitatory_Neuron.Slc17a6.Nell1_(Neuron.Slc17a6.Nell1)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.80e-04 | 69 | 25 | 2 | 96564b46008a6e5220b6596cbbe0a24e9b5955ee | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Slc17a6.Cbln1_(Entopeduncular_Nucleus_(Ent),_GABA/Glu_co-releasing)--|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.24e-04 | 76 | 25 | 2 | 47deea63d975366a42834c22cc163c4c7142d51d | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Slc17a6.Cbln1_(Entopeduncular_Nucleus_(Ent),_GABA/Glu_co-releasing)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.24e-04 | 76 | 25 | 2 | f653a09d6707d9b34db4ef486212aeba5610f47b | |
| ToppCell | Globus_pallidus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2-Slc17a6.Cbln1_(Entopeduncular_Nucleus_(Ent),_GABA/Glu_co-releasing)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 8.24e-04 | 76 | 25 | 2 | 079e1af894e670f63d718e16599f20d920643160 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Npsr1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.35e-04 | 81 | 25 | 2 | 5d9b08bc1ae6ecb894c88c9784fdc4203682d087 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Olfr558_(Mural.Rgs5Acta2.Olfr558)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.45e-03 | 101 | 25 | 2 | a05293ccd1de48ed8c7d1417f410d2c4be388c5b | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Olfr558_(Mural.Rgs5Acta2.Olfr558)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.45e-03 | 101 | 25 | 2 | b75b000b7899399d1e6aa692d2a4c33b41a1fe18 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cnn1_(Mural.Rgs5Acta2.Cnn1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.62e-03 | 107 | 25 | 2 | d4807f008619dfd3e215d602df0d02b135b1ac37 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cnn1_(Mural.Rgs5Acta2.Cnn1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.62e-03 | 107 | 25 | 2 | 5907b9632c88d48f293c3c6d37b7ef831fbcdd86 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.62e-03 | 107 | 25 | 2 | 3f24de1afbfd070f9db11c9acd02b90e5eb2511d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Cbln4|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.87e-03 | 115 | 25 | 2 | ac73aa06e617ed791c6ae9e38189bac74188c27b | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.10e-03 | 122 | 25 | 2 | eae9d94f8510ac0f434942451d55c7260977b178 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-03 | 125 | 25 | 2 | 9e98dcfdc768ae492f453efc08926164bbb0a909 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_ALM_Hpgd|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.24e-03 | 126 | 25 | 2 | 9b04ca8a46cc30119baf6ef27711a0b2a6b4a0c9 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Interneuron|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.24e-03 | 126 | 25 | 2 | ec445ec097c9c45cd47b8cfa8c140df5b298695e | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT-L5_PT_VISp_C1ql2_Ptgfr|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.27e-03 | 127 | 25 | 2 | fb58f4b4d3722f4b9a2e4946c0244c5b70dd883b | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Acta2Rgs5.Rgs5_(Mural.Acta2Rgs5.Rgs5)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.53e-03 | 134 | 25 | 2 | 1fa13185a4dfb4563473184c0c4f449011d88631 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Acta2Rgs5.Rgs5_(Mural.Acta2Rgs5.Rgs5)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.53e-03 | 134 | 25 | 2 | 1ab99a22d0d7657f62f8ea7d96bb24e88de54fd4 | |
| ToppCell | Cerebellum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 2.53e-03 | 134 | 25 | 2 | 8a3acf32cabc37b49d6488d43cdaae7cec79d119 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.53e-03 | 134 | 25 | 2 | cb676d5bbc468bd3ce1b6712d41c986ee9221ac5 | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-Erythroid|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.71e-03 | 139 | 25 | 2 | d96e5c17582f1576fa09d6bad35c418b6248448c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Mesoderm|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.71e-03 | 139 | 25 | 2 | d441c29852c28928ecb696b4b95e31b30c17116b | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L5_PT|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.75e-03 | 140 | 25 | 2 | 7cc891d676555609add6fc7880735d948a2ad801 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.83e-03 | 142 | 25 | 2 | e5608bbbc04edcdaafe1affc4db7f9d8edba04d9 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.91e-03 | 144 | 25 | 2 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | TCGA-Uterus|World / Sample_Type by Project: Shred V9 | 2.91e-03 | 144 | 25 | 2 | 7efb45286ebf2dbfb9125fd6373f28dccb029a2e | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.95e-03 | 145 | 25 | 2 | 78f5f4b96420c7f391e4d32a9ed151ed95fad90b | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.03e-03 | 147 | 25 | 2 | 8f725ff8fb4ced5db2643e80669d3f7945b820ab | |
| ToppCell | Mild/Remission-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.07e-03 | 148 | 25 | 2 | dd5e1bc02824e743e1c030a303e32f27a359a8ca | |
| ToppCell | 368C-Myeloid-Mast_cell|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.23e-03 | 152 | 25 | 2 | faf30245a1690aaa27c7be0832797c340e4af4d7 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-03 | 152 | 25 | 2 | d88d68a788a3256671ebbc06e104833f1f58f07d | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-03 | 152 | 25 | 2 | d5ba87b5d34e52cef8475befafea962d70fa8a1d | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.23e-03 | 152 | 25 | 2 | 32634195048858ae84605c61e43c542d90f7cab5 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid-myeloid_granulocytic-mast_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.23e-03 | 152 | 25 | 2 | 0eb185b2404f015efff1bd140e0c502d714720fb | |
| ToppCell | 368C-Myeloid-Mast_cell-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.23e-03 | 152 | 25 | 2 | 519c9ed05fdaf420e42147ffae1dc05a7f86fdd4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.27e-03 | 153 | 25 | 2 | ee6f4770c6e35d59bdeec5b0ecb10119fa8c3ca5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.27e-03 | 153 | 25 | 2 | 90cd6efda83c0b4b80eae2c90e7ff45dfd936dc2 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Dendritic|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.27e-03 | 153 | 25 | 2 | a35149a0c8b4ec9ad27cc4b3d34fba3b8714a6a2 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.27e-03 | 153 | 25 | 2 | d3fb83ca984c7583b1e51c364be6c7c17f67b048 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-03 | 154 | 25 | 2 | d76fd51a4587decbfe1dde1c8a9b880c5fa18e4a | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-Tfh|blood / Manually curated celltypes from each tissue | 3.32e-03 | 154 | 25 | 2 | 5ff380205fa7ab97ba21f6512bc9e14c0fb320b6 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.32e-03 | 154 | 25 | 2 | b6e982e341c6cfb6ff80a318078fcb10c36d182f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.36e-03 | 155 | 25 | 2 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 3.40e-03 | 156 | 25 | 2 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 3.40e-03 | 156 | 25 | 2 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | 3'_v3-Lung-Lymphocytic_T_CD8-Tnaive/CM_CD8|Lung / Manually curated celltypes from each tissue | 3.40e-03 | 156 | 25 | 2 | d691a4defda046c1bbcb13ef38ee9abbb628c33c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.44e-03 | 157 | 25 | 2 | 29622bac6b16bb39cec4319bf4c4f92d33345e8a | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-CD8_TCM|ICU-SEP / Disease, Lineage and Cell Type | 3.44e-03 | 157 | 25 | 2 | 8ff52e532b149887c18f76b151325281821692b5 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.44e-03 | 157 | 25 | 2 | 10989c7046fc859f137c7cef3296508d4476f11f | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-03 | 158 | 25 | 2 | 0edd9b005875f9a4f5446f5d5161f8ba63860793 | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-03 | 158 | 25 | 2 | 9fd77ebdd1babf1c85a85d38d9a15858ab08bc84 | |
| ToppCell | facs-Heart-RV-24m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.49e-03 | 158 | 25 | 2 | 2ef43d14ee65d004dc62c12ff209bbe12e4db681 | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.53e-03 | 159 | 25 | 2 | 29999c87f5823f734e5cbf8ea8b729ec017db9b3 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-5|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.53e-03 | 159 | 25 | 2 | c40fe552da3abdb1df87e9e1647468dc038bec0a | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.0.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.53e-03 | 159 | 25 | 2 | 4b840da854390f8285c219314cff4434d7ffcacc | |
| ToppCell | 5'-Airway_Nasal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.53e-03 | 159 | 25 | 2 | d9e535cf9a0a2302268f2897b010dcecc6426e41 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-03 | 160 | 25 | 2 | 2d391ba6f7adb55dfa89feecc10cc9ce97e5fe74 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.57e-03 | 160 | 25 | 2 | 8bcdbcfdf1e0ace6053e8de82762f6e2f86bba7a | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D|390C / Donor, Lineage, Cell class and subclass (all cells) | 3.62e-03 | 161 | 25 | 2 | b60b4fd34a3ad4bf1813e6cc24aa7e04f9e53e4c | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-03 | 161 | 25 | 2 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-03 | 162 | 25 | 2 | b936f8040dcd4db621ccded19237af8df7d0ed6e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-03 | 162 | 25 | 2 | 5f009b231f21861afee9cc0c569082e1135f929c | |
| ToppCell | Control-Epithelial-Ionocyte|World / Disease state, Lineage and Cell class | 3.66e-03 | 162 | 25 | 2 | e3b9b46ce2faff7d099502df14bbf51e9f183f8c | |
| ToppCell | Control-Epithelial-Ionocyte|Control / Disease state, Lineage and Cell class | 3.71e-03 | 163 | 25 | 2 | bf09fa39bf3e6b3a776d5e79c30c96df572956a3 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 3.71e-03 | 163 | 25 | 2 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tfh|GI_large-bowel / Manually curated celltypes from each tissue | 3.71e-03 | 163 | 25 | 2 | 4104d3b9748b39cb0744c9be76db21bdda566a0d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.71e-03 | 163 | 25 | 2 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | ASK428-Immune-Mast_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.71e-03 | 163 | 25 | 2 | 569ca0e8ce307f258910b0c75c498009a9651e6e | |
| ToppCell | NS-moderate-d_16-33-Myeloid-Mast_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.75e-03 | 164 | 25 | 2 | 35c673380f75cb4bfe080089bc723c4373bcc7a5 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-03 | 165 | 25 | 2 | 22293c6b55f44636440cd737efb786ff5de3373d | |
| ToppCell | COVID-19_Mild-PLT_0|COVID-19_Mild / Disease Group and Platelet Clusters | 3.79e-03 | 165 | 25 | 2 | 083a14d3b0162cee4e79f7398b8fb739582b39ff | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.2.4|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.79e-03 | 165 | 25 | 2 | 4d364e1aae41aea483d1311e5e8ef4fc33e30d5e | |
| ToppCell | critical-Myeloid-Mast_cell|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.79e-03 | 165 | 25 | 2 | 34a1cc6ccd46c059354e8fbde1ac69f202695a4e | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.79e-03 | 165 | 25 | 2 | 94a5211072464fc24592bb107a853ce832e816fe | |
| ToppCell | nucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.79e-03 | 165 | 25 | 2 | 640bb71e74a61df2fcb01ceeabe4c493ef836b21 | |
| Drug | 3,4-dihydroquinazoline | 1.69e-11 | 6 | 25 | 4 | CID000583065 | |
| Drug | CNS 1145 | 2.42e-10 | 33 | 25 | 5 | CID000190902 | |
| Drug | IHC-64 | 2.42e-10 | 33 | 25 | 5 | CID000162753 | |
| Drug | AC1L2VU3 | 5.56e-10 | 12 | 25 | 4 | CID000129572 | |
| Drug | 1,3-dioxoisoindoline-5-carboxamide | 1.17e-09 | 3 | 25 | 3 | CID010679219 | |
| Drug | pentasulfane | 2.04e-09 | 16 | 25 | 4 | CID000448216 | |
| Drug | Cinildipine | 3.84e-09 | 56 | 25 | 5 | CID000002752 | |
| Drug | nilvadipine | 5.47e-09 | 60 | 25 | 5 | CID000004494 | |
| Drug | IAA-94 | 5.95e-09 | 61 | 25 | 5 | CID000003667 | |
| Drug | lercanidipine | 7.02e-09 | 63 | 25 | 5 | CID000065866 | |
| Drug | gallopamil | 9.62e-09 | 67 | 25 | 5 | CID000001234 | |
| Drug | AC1L2AC7 | 1.12e-08 | 69 | 25 | 5 | CID000068733 | |
| Drug | Flunarizine | 1.17e-08 | 5 | 25 | 3 | DB04841 | |
| Drug | CAS 298-57-7 | 1.49e-08 | 73 | 25 | 5 | CID000002761 | |
| Drug | ethosuximide | 1.60e-08 | 74 | 25 | 5 | CID000003291 | |
| Drug | nisoldipine | 2.09e-08 | 78 | 25 | 5 | CID000004499 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 2.23e-08 | 79 | 25 | 5 | CID005287890 | |
| Drug | LY215840 | 4.08e-08 | 7 | 25 | 3 | CID000132049 | |
| Drug | manidipine | 5.65e-08 | 95 | 25 | 5 | CID000004008 | |
| Drug | isotetrandrine | 6.28e-08 | 97 | 25 | 5 | CID000005422 | |
| Drug | gadolinium | 6.38e-08 | 199 | 25 | 6 | CID000023982 | |
| Drug | nitrendipine | 6.61e-08 | 98 | 25 | 5 | CID000004507 | |
| Drug | isradipine | 7.32e-08 | 100 | 25 | 5 | CID000003784 | |
| Drug | loperamide | 9.36e-08 | 105 | 25 | 5 | CID000003954 | |
| Drug | Cinnarizine | 9.78e-08 | 9 | 25 | 3 | DB00568 | |
| Drug | lamotrigine | 1.54e-07 | 116 | 25 | 5 | CID000003878 | |
| Drug | AC1NBU2S | 1.61e-07 | 117 | 25 | 5 | CID004473765 | |
| Drug | Mibefradil | 1.92e-07 | 11 | 25 | 3 | DB01388 | |
| Drug | EBNs | 1.92e-07 | 11 | 25 | 3 | CID000150695 | |
| Drug | bepridil | 2.33e-07 | 126 | 25 | 5 | CID000002351 | |
| Drug | pimozide | 2.42e-07 | 127 | 25 | 5 | CID000016362 | |
| Drug | KW-3049 | 2.52e-07 | 50 | 25 | 4 | CID000002324 | |
| Drug | themisone | 2.56e-07 | 12 | 25 | 3 | CID000016235 | |
| Drug | tetralol | 3.32e-07 | 13 | 25 | 3 | CID000010747 | |
| Drug | Mibefradil | 3.32e-07 | 13 | 25 | 3 | ctd:D020748 | |
| Drug | lanthanum | 3.41e-07 | 136 | 25 | 5 | CID000023926 | |
| Drug | isovalerate | 4.37e-07 | 143 | 25 | 5 | CID000010430 | |
| Drug | Dantrolene-13C3 | 4.69e-07 | 145 | 25 | 5 | CID000002951 | |
| Drug | nimodipine | 4.69e-07 | 145 | 25 | 5 | CID000004497 | |
| Drug | nicardipine | 4.69e-07 | 145 | 25 | 5 | CID000004473 | |
| Drug | butamben | 5.27e-07 | 15 | 25 | 3 | CID000002482 | |
| Drug | Bay K 8644 | 5.55e-07 | 150 | 25 | 5 | CID000002303 | |
| Drug | procaine | 6.12e-07 | 153 | 25 | 5 | CID000004914 | |
| Drug | Verapamil | 6.49e-07 | 16 | 25 | 3 | DB00661 | |
| Drug | mibefradil | 6.87e-07 | 64 | 25 | 4 | CID000060662 | |
| Drug | AC1L1TJF | 7.78e-07 | 66 | 25 | 4 | CID000003377 | |
| Drug | Zonisamide | 7.87e-07 | 17 | 25 | 3 | DB00909 | |
| Drug | gabapentin | 1.00e-06 | 169 | 25 | 5 | CID000003446 | |
| Drug | felodipine | 1.00e-06 | 169 | 25 | 5 | CID000003333 | |
| Drug | lavendustin A | 1.06e-06 | 171 | 25 | 5 | CID000003894 | |
| Drug | Barium | 1.11e-06 | 72 | 25 | 4 | ctd:D001464 | |
| Drug | cyclopropanecarboxylic acid | 1.12e-06 | 19 | 25 | 3 | CID000015655 | |
| Drug | riluzole | 1.16e-06 | 174 | 25 | 5 | CID000005070 | |
| Drug | papaverine | 1.22e-06 | 176 | 25 | 5 | CID000004680 | |
| Drug | AC1L1KS5 | 1.33e-06 | 334 | 25 | 6 | CID000005631 | |
| Drug | NSC7524 | 1.44e-06 | 182 | 25 | 5 | CID000005657 | |
| Drug | baclofen | 1.83e-06 | 191 | 25 | 5 | CID000002284 | |
| Drug | NSC759576 | 1.83e-06 | 191 | 25 | 5 | CID000003075 | |
| Drug | dihydropyridine | 1.92e-06 | 193 | 25 | 5 | CID000104822 | |
| Drug | hydroxamates | 2.65e-06 | 25 | 25 | 3 | CID000033630 | |
| Drug | AC1NUZ8M | 2.96e-06 | 92 | 25 | 4 | CID000073211 | |
| Drug | SureCN2398996 | 3.47e-06 | 3 | 25 | 2 | CID010220069 | |
| Drug | N-desmethylmethsuximide | 3.47e-06 | 3 | 25 | 2 | CID000092154 | |
| Drug | phenytoin | 3.57e-06 | 219 | 25 | 5 | CID000001775 | |
| Drug | homovanillic acid | 3.66e-06 | 97 | 25 | 4 | CID000001738 | |
| Drug | rufinamide | 4.19e-06 | 29 | 25 | 3 | CID000129228 | |
| Drug | anacardic acid | 4.66e-06 | 30 | 25 | 3 | CID000167551 | |
| Drug | pyraclofos | 5.21e-06 | 106 | 25 | 4 | CID000093460 | |
| Drug | methsuximide | 6.94e-06 | 4 | 25 | 2 | CID000006476 | |
| Drug | NiCl2 | 8.24e-06 | 119 | 25 | 4 | CID000024385 | |
| Drug | gamma-aminobutyric acid | 9.98e-06 | 474 | 25 | 6 | CID000000119 | |
| Drug | amlodipine | 1.03e-05 | 126 | 25 | 4 | CID000002162 | |
| Drug | phensuximide | 1.16e-05 | 5 | 25 | 2 | CID000006839 | |
| Drug | AC1O7G5C | 1.16e-05 | 5 | 25 | 2 | CID006603942 | |
| Drug | Calcium | 1.25e-05 | 493 | 25 | 6 | ctd:D002118 | |
| Drug | U46619 | 1.28e-05 | 285 | 25 | 5 | CID000005618 | |
| Drug | AC1L1DXE | 1.62e-05 | 299 | 25 | 5 | CID000002548 | |
| Drug | AC1MQ5W8 | 1.73e-05 | 6 | 25 | 2 | CID003396482 | |
| Drug | cerebrocrast | 1.73e-05 | 6 | 25 | 2 | CID000159556 | |
| Drug | ATN-2 | 1.73e-05 | 6 | 25 | 2 | CID003081684 | |
| Drug | 8-bromoguanosine 3',5'-cyclic monophosphate | 1.87e-05 | 308 | 25 | 5 | CID000001915 | |
| Drug | barium | 1.95e-05 | 148 | 25 | 4 | CID000104810 | |
| Drug | halothane | 2.05e-05 | 314 | 25 | 5 | CID000003562 | |
| Drug | mercury | 2.13e-05 | 542 | 25 | 6 | CID000023931 | |
| Drug | procymidone | 2.34e-05 | 155 | 25 | 4 | ctd:C035988 | |
| Drug | losigamone | 2.42e-05 | 7 | 25 | 2 | CID000060572 | |
| Drug | dimethylmercury | 2.49e-05 | 52 | 25 | 3 | CID000011645 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | 3.03e-05 | 577 | 25 | 6 | CID000000295 | |
| Drug | Landel | 4.15e-05 | 9 | 25 | 2 | CID000163838 | |
| Drug | zonisamide | 4.24e-05 | 62 | 25 | 3 | CID000005734 | |
| Drug | Lovastatin [75330-75-5]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 4.97e-05 | 188 | 25 | 4 | 2854_UP | |
| Drug | valproate | 5.15e-05 | 381 | 25 | 5 | CID000003121 | |
| Drug | ZD7288 | 5.18e-05 | 10 | 25 | 2 | CID000123983 | |
| Drug | Norethindrone [68-22-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | 5.62e-05 | 194 | 25 | 4 | 5055_UP | |
| Drug | Cephalosporanic acid, 7-amino [957-68-6]; Down 200; 14.6uM; PC3; HT_HG-U133A | 5.62e-05 | 194 | 25 | 4 | 4242_DN | |
| Drug | clofibrate; Up 200; 150uM; MCF7; HG-U133A | 5.62e-05 | 194 | 25 | 4 | 263_UP | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 5.73e-05 | 195 | 25 | 4 | 6059_DN | |
| Drug | Tobramycin [32986-56-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 5.73e-05 | 195 | 25 | 4 | 4162_UP | |
| Drug | cobalt-60 | 5.76e-05 | 390 | 25 | 5 | CID000061492 | |
| Drug | glutamate | 5.79e-05 | 962 | 25 | 7 | CID000000611 | |
| Disease | dentatorubral-pallidoluysian atrophy (implicated_via_orthology) | 6.34e-07 | 2 | 24 | 2 | DOID:0060162 (implicated_via_orthology) | |
| Disease | Peripheral Nervous System Diseases | 1.14e-05 | 54 | 24 | 3 | C4721453 | |
| Disease | cortical surface area measurement | 7.03e-05 | 1345 | 24 | 7 | EFO_0010736 | |
| Disease | Tourette syndrome, schizophrenia | 9.62e-05 | 18 | 24 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | Global developmental delay | 1.69e-04 | 133 | 24 | 3 | C0557874 | |
| Disease | mean corpuscular hemoglobin concentration | 2.05e-04 | 1105 | 24 | 6 | EFO_0004528 | |
| Disease | migraine disorder, glucose measurement | 2.91e-04 | 31 | 24 | 2 | EFO_0004468, MONDO_0005277 | |
| Disease | Intellectual Disability | 4.34e-04 | 447 | 24 | 4 | C3714756 | |
| Disease | Seizures | 7.18e-04 | 218 | 24 | 3 | C0036572 | |
| Disease | renal agenesis, unilateral | 1.13e-03 | 61 | 24 | 2 | MONDO_0019636 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 1.20e-03 | 63 | 24 | 2 | DOID:0050866 (is_marker_for) | |
| Disease | obsolete aging | 1.46e-03 | 279 | 24 | 3 | GO_0007568 | |
| Disease | schizophrenia (is_implicated_in) | 1.83e-03 | 78 | 24 | 2 | DOID:5419 (is_implicated_in) | |
| Disease | Abnormality of refraction | 1.98e-03 | 673 | 24 | 4 | HP_0000539 | |
| Disease | Hodgkins lymphoma | 2.02e-03 | 82 | 24 | 2 | EFO_0000183 | |
| Disease | schizophrenia, intelligence, self reported educational attainment | 2.69e-03 | 346 | 24 | 3 | EFO_0004337, EFO_0004784, MONDO_0005090 | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 2.93e-03 | 99 | 24 | 2 | DOID:11446 (biomarker_via_orthology) | |
| Disease | Vitiligo | 3.05e-03 | 101 | 24 | 2 | EFO_0004208 | |
| Disease | opioid use disorder | 3.05e-03 | 101 | 24 | 2 | EFO_0010702 | |
| Disease | response to tenofovir, creatinine clearance measurement | 3.73e-03 | 112 | 24 | 2 | EFO_0007934, EFO_0009279 | |
| Disease | lymphocyte measurement | 4.06e-03 | 117 | 24 | 2 | EFO_0803546 | |
| Disease | autoimmune thyroid disease | 4.70e-03 | 126 | 24 | 2 | EFO_0006812 | |
| Disease | cup-to-disc ratio measurement | 4.95e-03 | 430 | 24 | 3 | EFO_0006939 | |
| Disease | cannabis dependence | 5.37e-03 | 135 | 24 | 2 | EFO_0007191 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HQVHHHGRSRHHEAH | 221 | Q8NEC5 | |
| HHQHSHIHSHLHLHQ | 1051 | P54259 | |
| HHYRSHHPTLHHSHH | 1246 | Q5VU97 | |
| QQQQQQHHHHHHHHL | 481 | Q9NSY1 | |
| QHHHHHHHHLLQDAY | 486 | Q9NSY1 | |
| QASSHHHHHRCHRRR | 2046 | Q00975 | |
| HSNHRHHAHHAHPRA | 146 | Q2Q1W2 | |
| HHHHHRHSSSHHKIS | 176 | Q5HYJ3 | |
| HHHHHHHRSPGRSQH | 926 | O15083 | |
| PVIQRHEHHHHHEHH | 426 | Q969F2 | |
| YLRDHHHRHHHHQES | 21 | Q7RTU3 | |
| RAPSRRRHHHHNHHH | 506 | O43900 | |
| HNHHHHHNRHPSRRR | 516 | O43900 | |
| HRRLSVHHLVHHHHH | 486 | O43497 | |
| AAGLHHHRHVHHHVH | 526 | O15169 | |
| HHRHVHHHVHHSTAR | 531 | O15169 | |
| HHGPHLAHRHRHHRR | 1041 | Q9P0X4 | |
| HLVADATQHHHHLHH | 76 | Q9NY43 | |
| RLQRHRHRHHRHHHH | 66 | Q3B7T3 | |
| RHHHHHHHHRRRRHR | 76 | Q3B7T3 | |
| TASVHHLVYHHHHHH | 511 | O95180 | |
| MHDHNHRLRHHHRLH | 171 | Q9ULF5 | |
| HRLRHHHRLHHHLDH | 176 | Q9ULF5 | |
| HHRLHHHLDHNNTHH | 181 | Q9ULF5 | |
| RSHRMRRHHHHHQHH | 1276 | O14594 | |
| HHQHHHQHHHHKSRK | 1286 | O14594 | |
| HHHHHHHHHGRDFLL | 326 | Q9BYZ6 | |
| RHHHHLRHHAHPHHL | 76 | Q8IW03 | |
| HHQHSHIHSHLHLHQ | 1426 | Q9P2R6 | |
| SEHHHHILRHGHRGH | 171 | P23327 | |
| TRRSHRHHEHLTQHH | 186 | Q9BY31 | |
| YMRHHHPHAHMHHRH | 226 | A8MV65 |